Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Techne (TECH) Operating Income (2016 - 2026)

Bio-Techne has reported Operating Income over the past 17 years, most recently at $54.5 million for Q4 2025.

  • For Q4 2025, Operating Income rose 14.85% year-over-year to $54.5 million; the TTM value through Dec 2025 reached $117.0 million, down 41.58%, while the annual FY2025 figure was $102.3 million, 50.53% down from the prior year.
  • Operating Income for Q4 2025 was $54.5 million at Bio-Techne, up from $47.7 million in the prior quarter.
  • Over five years, Operating Income peaked at $94.5 million in Q2 2023 and troughed at -$23.9 million in Q2 2025.
  • A 5-year average of $57.2 million and a median of $59.3 million in 2021 define the central range for Operating Income.
  • Biggest five-year swings in Operating Income: soared 74.46% in 2021 and later crashed 152.07% in 2025.
  • Year by year, Operating Income stood at $62.3 million in 2021, then increased by 8.89% to $67.9 million in 2022, then plummeted by 44.02% to $38.0 million in 2023, then rose by 24.77% to $47.4 million in 2024, then grew by 14.85% to $54.5 million in 2025.
  • Business Quant data shows Operating Income for TECH at $54.5 million in Q4 2025, $47.7 million in Q3 2025, and -$23.9 million in Q2 2025.